Cargando…
A Case Report of a 58-Year-Old Woman with a Diagnosis of High-Risk Myeloma Refractory to Multiple Line of Therapy and Treated with Selinexor, Bortezomib, and Dexamethasone Prior to Allogeneic Stem Cell Transplantation
Patient: Female, 40-year-old Final Diagnosis: Multiple myeloma Symptoms: Anaemia Medication:— Clinical Procedure: — Specialty: Hematology • Oncology • Transplantology OBJECTIVE: Unusual clinical course BACKGROUND: Approximately 10% to 15% of patients with multiple myeloma (MM) are diagnosed with hig...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040079/ https://www.ncbi.nlm.nih.gov/pubmed/35444159 http://dx.doi.org/10.12659/AJCR.935353 |